Company research
Entasis Therapeutics Holdings Inc.
CIK 1724344Updated Nov 16, 2026
Securities
Historical securities (1)
ETTX · NASDAQ · equity · closed Jul 11, 2022Name history
Entasis Therapeutics Ltd · through Aug 17, 2018
ETTX price & chart
Historical security
This listing closed Jul 11, 2022. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2021 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 40,920,000Source | 61,558,000Source | 51,034,000Source | 89,274,000Source |
| Property, Plant and Equipment, NetUSD | 198,000Source | 222,000Source | 345,000Source | 419,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 32,307,000Source | 53,247,000Source | 16,034,000Source | 49,360,000Source |
| Assets, CurrentUSD | 39,815,000Source | 60,132,000Source | 49,006,000Source | 88,792,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | — | — | — | 1,994,000Source |
| Operating Lease, Right-of-Use AssetUSD | 604,000Source | 1,141,000Source | 1,620,000Source | — |
| Other Assets, NoncurrentUSD | 303,000Source | 63,000Source | 63,000Source | 63,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 9,708,000Source | 9,269,000Source | 8,877,000Source | 6,391,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 48,000Source | 37,000Source | 13,000Source | 13,000Source |
| Retained Earnings (Accumulated Deficit)USD | -231,596,000Source | -184,455,000Source | -133,959,000Source | -90,109,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | — | — | -9,000Source |
| Stockholders' Equity Attributable to ParentUSD | 31,212,000Source | 52,289,000Source | 42,157,000Source | 82,883,000Source |
| Additional Paid in Capital, Common StockUSD | 262,760,000Source | 236,707,000Source | 176,103,000Source | 172,988,000Source |
| Liabilities and EquityUSD | 40,920,000Source | 61,558,000Source | 51,034,000Source | 89,274,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 9,708,000Source | 8,565,000Source | 7,556,000Source | 6,216,000Source |
| Operating Lease, Liability, CurrentUSD | 704,000Source | 617,000Source | 506,000Source | — |
| Accounts Payable, CurrentUSD | 1,183,000Source | 660,000Source | 1,304,000Source | 1,370,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | 704,000Source | 1,321,000Source | — |
| Additional Financial Items | ||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 41,000,000Source | 85,100,000Source |
| Dividends PayableUSD | 0Source | 0Source | 0Source | 0Source |
| Short-term InvestmentsUSD | — | — | 24,962,000Source | 35,732,000Source |
cash flow · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -47,141,000Source | -50,496,000Source | -43,850,000Source | -32,952,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 104,000Source | 141,000Source | 142,000Source | 164,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 4,023,000Source | 2,951,000Source | 2,421,000Source | 1,201,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 513,000Source | -644,000Source | -30,000Source | 133,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -42,972,000Source | -45,426,000Source | -44,743,000Source | -35,817,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -70,000Source | 24,982,000Source | 11,360,000Source | -36,091,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 70,000Source | 18,000Source | 105,000Source | 370,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 22,102,000Source | 57,657,000Source | 57,000Source | 66,167,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -20,940,000Source | 37,213,000Source | -33,326,000Source | -5,741,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 32,307,000Source | 53,247,000Source | 16,034,000Source | 49,360,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | — | — | 677,000Source | 472,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 4,023,000Source | 2,951,000Source | 2,421,000Source | 1,201,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 41,000,000Source | 85,100,000Source |
| Dividends PayableUSD | 0Source | 0Source | 0Source | 0Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | -282,000Source |
| General and Administrative ExpenseUSD | 15,212,000Source | 13,209,000Source | 13,770,000Source | 10,161,000Source |
| Income Tax Expense (Benefit)USD | — | 0Source | 677,000Source | 472,000Source |
| Net Income (Loss) Attributable to ParentUSD | -47,141,000Source | -50,496,000Source | -43,850,000Source | -32,952,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -47,141,000Source | -50,496,000Source | -43,850,000Source | -42,094,000Source |
| Operating ExpensesUSD | 52,317,000Source | 54,231,000Source | 53,936,000Source | 43,207,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | 52,000Source | 96,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 7,000,000Source | 5,000,000Source |
income statement · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -52,317,000Source | -54,231,000Source | -46,936,000Source | -38,207,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -47,141,000Source | -50,496,000Source | -43,173,000Source | -32,480,000Source |
| Income Tax Expense (Benefit)USD | — | 0Source | 677,000Source | 472,000Source |
| Net Income (Loss) Attributable to ParentUSD | -47,141,000Source | -50,496,000Source | -43,850,000Source | -32,952,000Source |
| Earnings Per Share, BasicUSD per share | -1.09Source | — | — | — |
| Earnings Per Share, DilutedUSD per share | -1.09Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 43,340,826Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 43,340,826Source | — | — | — |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | — | — | 677,000Source | — |
| General and Administrative ExpenseUSD | 15,212,000Source | 13,209,000Source | 13,770,000Source | 10,161,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -18,730,000Source | -12,216,000Source | -10,448,000Source | -4,357,000Source |
| Interest Income, OtherUSD | 13,000Source | 173,000Source | 1,463,000Source | 390,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -47,141,000Source | -50,496,000Source | -43,850,000Source | -42,094,000Source |
| Operating ExpensesUSD | 52,317,000Source | 54,231,000Source | 53,936,000Source | 43,207,000Source |
| Research and Development ExpenseUSD | 37,105,000Source | 41,022,000Source | 40,166,000Source | 33,046,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 7,000,000Source | 5,000,000Source |
| Undistributed Earnings (Loss) Allocated to Participating Securities, BasicUSD | — | — | — | 9,142,000Source |